Anish Bhatnagar
Net Worth

Last updated:

What is Anish Bhatnagar net worth?

The estimated net worth of Dr. Anish Bhatnagar is at least $23,799,374 as of 1 Jul 2024. He owns shares worth $8,921,407 as insider, has earned $7,317,967 from insider trading and has received compensation worth at least $7,560,000 in Soleno Therapeutics, Inc..

What is the salary of Anish Bhatnagar?

Dr. Anish Bhatnagar salary is $756,000 per year as Pres, Chief Executive Officer, Chief Operating Officer & Director in Soleno Therapeutics, Inc..

How old is Anish Bhatnagar?

Dr. Anish Bhatnagar is 55 years old, born in 1970.

What stocks does Anish Bhatnagar currently own?

As insider, Dr. Anish Bhatnagar owns shares in one company:

Company Title Shares Price per share Total value
Soleno Therapeutics, Inc. (SLNO) Pres, Chief Executive Officer, Chief Operating Officer & Director 133,534 $66.81 $8,921,407

What does Soleno Therapeutics, Inc. do?

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

SLNO logo
SLNO
Soleno Therapeutics, Inc.
$66.81

Anish Bhatnagar insider trading

Soleno Therapeutics, Inc.

Dr. Anish Bhatnagar has made 14 insider trades between 2015-2024, according to the Form 4 filled with the SEC. Most recently he sold 4,198 units of SLNO stock worth $173,050 on 1 Jul 2024.

The largest trade he's ever made was exercising 60,000 units of SLNO stock on 31 Mar 2022. As of 1 Jul 2024 he still owns at least 133,534 units of SLNO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 4,198 $41.22 $173,050
Sale
Common Stock 15,058 $41.63 $626,789
Sale
Common Stock 11,383 $41.12 $468,103
Sale
Common Stock 7,597 $41.67 $316,544
Sale
Common Stock 2,527 $48.3 $122,054
Sale
Common Stock 6,931 $37.01 $256,496
Sale
Common Stock 35,272 $36 $1,269,721
Sale
Common Stock 51,205 $35.26 $1,805,488
Sale
Common Stock 27,716 $28.65 $794,119
Sale
Common Stock 14,317 $27.43 $392,672
Sale
Common Stock 13,510 $28.27 $381,860
Sale
Common Stock 4,458 $27.6 $123,019
Sale
Common Stock 21,220 $27.03 $573,492
Purchase
Warrant (right to buy) 60,000 $0.3 $18,000
Purchase
Common Stock 60,000 N/A N/A
Sale
Common Stock 39,033 $0.37 $14,559
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Option
Common Stock 58,419 N/A N/A
Option
Employee Stock Option 58,419 N/A N/A
Purchase
Common Stock 10,000 N/A N/A

Soleno Therapeutics key executives

Soleno Therapeutics, Inc. executives and other stock owners filed with the SEC: